PQ 526
526. Deputy Billy Kelleher asked the Minister for Health the reason the ten Irish sufferers of MPS IVA morquio disease cannot receive the medication Vimizin for treatment through local hospital based care or home care, similar to children in the UK with this condition and many others on mainland Europe. [11490/17]
Introduced
7 March 2017
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
7 March 2017
Summary
526. Deputy Billy Kelleher asked the Minister for Health the reason the ten Irish sufferers of MPS IVA morquio disease cannot receive the medication Vimizin for treatment through local hospital based care or home care, similar to children in the UK with this condition and many others on mainland Europe. [11490/17]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 7 March 2017
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2017-03-07/526/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2017-03-07/pq_526